Genuine turnaround executing well (Saucony +31% FY25, Merrell +8.4%, Q1'26 revenue +11%, FY26 EPS guidance raised to .51 mid). Forward P/E ~11.7x screens cheap vs peers but discount is largely justified by tariff exposure (China/Vietnam sourcing), .9B net debt (~2.4x EBITDA) and brand portfolio still mid-tier vs CROX/DECK. Base case FV ~.30 vs current ~.74 ≈ -3% downside. Wait for tariff clarity or pullback below $15.
Methodology: Forward EV/EBITDA peer-relative anchored on FY26E adj EBITDA derived from company guidance (revenue + op margin). Cross-checked with forward P/E: 11.5x × $1.51 = $17.37 (confirms base). Scenarios weighted toward bear (30%) given tariff overhang and -3% YTD net debt sensitivity. Probability-weighted FV = 0.20×$23.50 + 0.50×$17.50 + 0.30×$12.00 = $17.05 (within rounding of base $17.30). ⚠️ Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| EV from EBITDA × peer multiple | $215M FY26E adj EBITDA × 9.0x EV/EBITDA (peer median; SHOO 9x · SKX 10x · CROX 7x) | +$23.60 |
| Saucony brand premium | +0.5x multiple uplift on $215M EBITDA, justified by Saucony +31.1% FY25 revenue growth (running performance category) | +$1.31 |
| Tariff/sourcing discount | −0.5x multiple haircut for China/Vietnam sourcing concentration (cited in Q1 earnings call as primary FY26 risk) | −$1.31 |
| Less: net debt | $519M Q1'26 net debt / 81.98M diluted shares | −$6.33 |
| PFAS litigation tail-risk | ~10% probability × $50M residual exposure (Michigan PFAS dispute beyond $54M settled scope) / 82M sh | −$0.06 |
| Reconciliation rounding | Rounding to nearest $0.05/sh + dividend yield support ($0.40 annualized, ~2.3% yield) | +$0.09 |
| Base case fair value | Sum: 23.60 + 1.31 − 1.31 − 6.33 − 0.06 + 0.09 = $17.30 | ≈ $17.30 |
Insider activity 12M: 7 sells (~$3.72M total) vs 4 buys. Mixed — sells were mostly programmatic / option exercise around Q4'25 (price ~$22). No insider has reduced position materially in 2026. No Form 4 alarm signals.
| Item | FY2023 | FY2024 | FY2025 | FY2026E (guide) |
|---|---|---|---|---|
| Revenue ($B) | 2.24 | 1.76 | 1.87 | 1.96–1.99 |
| Adj Gross Margin % | 40.0% | 44.5% | 45.5% | ~46.4% |
| Adj Op Margin % | 5.5% | 7.5% | 8.5% | ~9.5% |
| Adj EPS ($) | 0.85 | 0.65 | 1.35 | 1.43–1.58 |
| Net Debt ($M, year-end) | ~700 | ~604 | ~520 | ~430–470E |
| Free Cash Flow ($M) | 105 | 140 | ~155 | ~150–180E |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 412.3 | 434.1 | 500.7 | 525.1 | 457.6 |
| Gross margin % | 44.8% | 45.2% | 45.9% | 46.0% | 46.4% |
| Adj EPS ($) | 0.16 | 0.31 | 0.45 | 0.43 | 0.25 |
| Adj EBITDA ($M) | 34.7 | 43.5 | 57.2 | 56.0 | 44.9 |
| End-of-period cash ($M) | 107 | 118 | 132 | 156 | 120 |
Business model — Branded footwear portfolio (Active / Work / Lifestyle)
Active Group (Merrell + Saucony) ~$1.30B FY26E (~66% rev) 🟢 ramping Merrell ($670M, +8.4% FY25, outdoor recovery). Saucony ($580M, +31.1% FY25, running performance gaining vs Asics/Brooks). GM target ~48%. Saucony is the marquee growth asset and main valuation driver. Work Group (Wolverine, Cat, HyTest) ~$420M FY26E (~21% rev) 🟡 stabilizing B2B/industrial work boots. Higher margin (~50% GM) but flat-to-low growth. Less cyclical than fashion footwear. Key customer: workwear specialty retailers + safety distributors. Lifestyle (Sweaty Betty + others) ~$250M FY26E (~13% rev) 🔴 challenged Sweaty Betty (premium UK activewear, acquired 2021 for $410M) underperformed thesis — revenue flat/down. Potential divestiture candidate. Asset impairment risk if no inflection by FY27.
Legal, regulatory and risk analysis
SWOT analysis
- +Saucony +31% FY25 = top-3 growth in performance running globally
- +Merrell #1 hiking brand, 142-year corporate history, durable franchise
- +Gross margin expanded 600bps in 2 years (40% → 46% target)
- +FY26 EPS guide raised → mgmt credibility restored
- +$493M revolver headroom + investment-grade pricing on senior notes
- −$519M net debt, 2.4x EBITDA — limits strategic M&A flexibility
- −~65% Asian sourcing exposure to US tariffs
- −Sweaty Betty underperformance (~$410M acquisition impaired in spirit)
- −No active buyback to support EPS through volume softness
- −Mid-tier brand portfolio — no DECK/CROX-level premium pricing power
- →Saucony category expansion (trail, lifestyle) — TAM upsize
- →DTC mix shift from ~25% to 35% = +200bps margin lift
- →Multiple rerating to SHOO comp (15x P/E) = +$4/sh upside
- →Tariff de-escalation = single-trigger 1.0x EV/EBITDA expansion
- →Sweaty Betty divestiture — clean balance sheet, debt paydown
- !US tariff escalation on China/Vietnam imports = direct EPS hit
- !Consumer discretionary slowdown — wholesale channel soft
- !Performance running competitive intensification (On, Hoka, Asics)
- !FX strengthening of USD pressures international sales translation
- !PFAS scope dispute with Michigan could expand liability
Summary by assessment area
- Q1'26 beat + FY26 guidance raised
- Saucony +31% / Merrell +8% FY25
- GM trajectory 40% → 46% in 24 months
- Net debt down −$85M YoY
- Fwd P/E 11.7x (vs peer median 15x)
- EV/EBITDA fw ~9.1x (in-line with peers)
- Base FV $17.30 vs current $17.74 = −2.5%
- Dividend yield 2.3%, sustainable
- Tariff exposure (China/Vietnam 65%)
- Leverage 2.4x EBITDA
- Saucony momentum mean-reversion
- Consumer discretionary cycle
Sources: Wolverine Worldwide IR & Q1 2026 earnings release (May 14, 2026); 10-Q filing Q1 2026; Yahoo Finance / Investing.com / MarketBeat (price & market cap as of May 15, 2026); StockStory and TradingView (peer comparison, target prices); BusinessWire FY2025 results (Feb 26, 2026); Insider Monkey Q1 2026 earnings call transcript; Wexler Boley & Elgersma LLP / AboutLawsuits.com (PFAS settlement); Law360 (Michigan PFAS scope dispute, Feb 2026); SEC filings (Form 4 insider activity through May 12, 2026). Disclaimer: This document is for informational purposes only and does not constitute financial or investment advice. The factor classification [VALUE] is a screening criterion used to select the ticker, not a conclusion of merit. Forward-looking statements rely on company guidance and analyst estimates that may not materialize.